Ludwig-Maximilians-University
Munich, 80333, Germany
NCT Number: NCT01150734
Muscle evoked potentials (MEP) are supposed to different in schizophrenic and depressed patients, compared to a sample of healthy volunteers. Transcranial Magnetic Stimulation (TMS)-evoked MEP are measured in all three groups at baseline and after tDCS (2 mA, 20 minutes). MEP amplitudes are supposed to normalize quickly in healthy volunteers, to stay diminished in depressed patients and to stay elevated in schizophrenic patients. These differences should disappear after regular pharmacological treatment. Outcome measures will be done in week 2 and week 4.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Munich, 80333, Germany
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at baseline
MEP amplitudes are supposed to be lower than in healthy controls or schizophrenic patients
Time frame: at baseline
MEP amplitued are supposed to be elevated in schizophrenic patients in comparison to depressed patients or healthy controls
Time frame: 4 weeks after baseline
MEP aplitued of schizophrenic patients are supposed to normalize after regular drug treatment within 4 weeks.
Time frame: 4 weeks after baseline
MEP aplitued of depressed patients are supposed to normalize after regular drug treatment within 4 weeks.
Ludwig-Maximilians - University of Munich
Other
Transcranial Direct Current Stimulation (tDCS)-Boosted Changes in Muscle Evoked Potentials (MEP) in Depressed and Schizophrenic Patients Reveal Deficits in Neuromodulation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01466439
Behavior, Behavioral Symptoms
Caen, France
View Trial DetailsNCT06038955
Behavior, Behavioral Symptoms
Frederiksberg, Capital Region of Copenhagen, Denmark
View Trial DetailsNCT03451630
Anxiety, Anxiety Disorders
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT02022462
Behavior, Behavioral Symptoms
Santa Fe Springs, California, United States
View Trial Details